Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Prostatic Neoplasms 9Breast Neoplasms 2Skin Diseases 1Salivary Gland Neoplasms 1Rare Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Granulosa cell tumor of the ovary 1Endocrine System Diseases 1Acanthosis Nigricans 1

Interventions

Cytarabine 13fludarabine phosphate 10Peripheral Blood Stem Cell Transplantation 8Etoposide 7Busulfan 7Methotrexate 6Cyclophosphamide 6Azacitidine 6Vorinostat 5Idarubicin 5Filgrastim 5Decitabine 5Daunorubicin 5tipifarnib 4Topotecan 4Carboplatin 4Biopsy 4veliparib 3sargramostim 3laromustine 3entinostat 3Thioguanine 3Tacrolimus 3Sunitinib 3Lenalidomide 3Imatinib Mesylate 3Cyclosporine 3Antilymphocyte Serum 3romidepsin 2merphos 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Leukemia, Myelomonocytic, Chronic × Leuprolide × Clear all
NCT01338987 2021-03-18

Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
76 enrolled 16 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡